Abstract
The HLA-A28* molecule expressed by the B-cell line IDF is serologically distinct and intermediate between HLA-A28 and HLA-A2. Comparative tryptic peptide mapping of biosynthetically labeled HLA-A28*, A28, and A2 molecules showed that HLA-A28* is also chemically distinct. Reverse-phase high pressure liquid chromatographic analysis of tryptic peptides labeled with 3H-arginine and 3H-lysine revealed that A28*. A28, and A2 share ∼ 65% of their tryptic peptides. Multiple differences were observed between A28* and both A28 and A2. No peptides unique to A28* were detected and 25 peptides were shared with both A28 and A2. These results show that A28* is a novel HLA product that is closely related to A28 and A2. Tryptic peptide map comparisons of these molecules labeled separately with 11 amino acids confirm these results. The data suggest that HLA-A28 * may have arisen from a genetic exchange event involving HLA-A28 and -A2. These data are consistent with the hypothesis that A28* is identical with A28 in the first extracellular domain (α 1) and identical with A2 in the second domain (α 2).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- EDTA:
-
ethylenediaminetetraacetic acid
- HPLC:
-
high-pressure liquid chromatography
- MHC:
-
major histocompatibility complex
- NP40:
-
Nonidet P40
- PMSF:
-
phenylmethylsulphonylfluoride
- SDS-PAGE:
-
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
- TPCK:
-
L(tosylamido-2-phenyl) ethyl chloromethyl ketone
- Tris:
-
tris (hydroxymethyl)-aminomethane
- A:
-
alanine
- C:
-
cysteine
- D:
-
aspartic acid
- E:
-
glutamic acid
- G:
-
glycine
- H:
-
histidine
- K:
-
lysine
- L:
-
leucine
- M:
-
methionine
- N:
-
asparagine
- Q:
-
glutamine
- R:
-
arginine
- S:
-
serine
- T:
-
threonine
- V:
-
valine
- W:
-
tryptophan
- Y:
-
tyrosine
References
Brodsky, F. M., Parham, P., Barnstable, C. J., Crumpton, M. J., and Bodmer, W. F.: Monoclonal antibodies for analysis of the HLA system. Immunol. Rev. 47: 3–61, 1979
Chen, T. R.: In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp. Cell Res. 104: 255–262, 1977
Coligan, J. E., Gates, F. T., Kimball, E. S., and Maloy, W. E.: Radiochemical sequence analysis of biosynthetically labeled proteins. Methods Enzymol. 91: 413–434, 1983
Ellis, S. A., Taylor, C., and McMichael, A. J.: Recognition of HLA-1327 and related antigen by a monoclonal antibody. Hum. Immunol. 5: 49–60, 1982
Kessler, S. W.: Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody antigen complexes with protein A. J. Immunol. 115: 1617–1624, 1975
Kimball, E. S. and Coligan, J. E.: Structure of class 1 major histocompatibility antigens. Contemp. Top. Mol. Immunol. 9: 1–63, 1983
Laemmli, U. K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685, 1970
Lopez de Castro, J. A., Strominger, J. L., Strong, D. M., and Orr, H. T.: Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA-A2: possible implications for the generation of HLA polymorphism. Proc. Natl. Acad. Sci. U.S.A. 79: 3813–1817, 1982
McMichael, A. J., Parham, P., Rust, N., and Brodsky, F.: A monoclonal antibody that recognizes an antigenic determinant shared by HLA-A2 and B17. Hum. Immunol. 1: 121–129, 1980
Parham, P.: Monoclonal antibodies against HLA products and their use in immunoaffinity purification. Methods Enzymol. 92: 110–138, 1983
Parham, P. and Bodmer, W. F.: Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2. Nature 276: 397–399, 1978
Parham, P., Alpert, B. N., Orr, H. T., and Strominger, J. L.: The carbohydrate moiety of HLA antigens: structure, antigenic properties and amino acid sequences around the site of glycosylation. J. Biol. Chem. 252: 7555–7567, 1977
Parham, P., Androlewicz, M. J., Brodsky, F. M., Holmes, N. J., and Ways, J.: Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class 1 MHC antigens. J. Immunol. Methods 53: 133–173, 1982
Ploegh, H. L., Orr, H. T., and Strominger, J. L.: Major histocompatibility antigens: The human (HLA-A, -B,-C) and murine (H-2K, H-2D) class 1 molecules. Cell 24: 287–299, 1981
Russo, C., Ng, A-K., Pellegrino, M. A., and Ferrone, S.: The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells. Immunogenetics 18: 23–35, 1983
Schulze, D. H., Pease, L. R., Geier, S. S., Reyes, A. A., Sarmiento, L. A., Wallace, R. B., and Nathenson, S. G.: Comparison of the cloned H-2Kbm1 variant gene with the H-2Kb gene shows a cluster of seven nucleotide differences. Proc. Natl. Acad. Sci. U.S.A. 80: 2007–2011, 1983
Terasaki, P. I.: Nomenclature for factors of the-HLA system 1980. In Histocompatibility Testing 1980, pp. 18–20, Munksgaard, Copenhagen, 1980
Ways, J. P. and Parham, P.: The binding of monoclonal antibodies to cell-surface molecules. A quantitative analysis with immunoglobulin G against two alloantigenic determinants of the human transplantation antigen HLA-A2. Biochem. J. 216: 423–432, 1983
Weiss, E. H., Mellor, A., Golden, L., Fahrner, K., Simpson, E., Hurst, J., and Flavell, R. A.: The structure of a mutant H-2 gene suggests that the generation of polymorphism in H-2 genes may occur by gene conversion-like events. Nature 301: 671–674, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holmes, N., Parham, P. Molecular characterization of HLA-A28*, a novel HLA product, and its relationship to HLA-A28 and HLA-A2. Immunogenetics 20, 103–115 (1984). https://doi.org/10.1007/BF00364482
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00364482